• Shares are up 16% to $21.32 today, driven by an upgrade from Keefe, Bruyette & Woods to "Outperform".
  • The move follows a 12.65% drop on July 29 after its Q2 report, which included a 42% sequential revenue jump and a 530 MW partnership with AMD, despite a net loss primarily due to a non-cash warrant adjustment.
  • Analysts reversed a prior downgrade, boosting investor confidence in Core Scientific's AI pivot and data center expansion.